The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Real-time central review: A report of the first 3,000 patients enrolled on the Children’s Oncology Group Renal Tumor Biology and Risk Stratification protocol AREN03B2.
Elizabeth Anne Mullen
No relevant relationships to disclose
James I. Geller
No relevant relationships to disclose
Eric J. Gratias
No relevant relationships to disclose
Elizabeth Jones Perlman
No relevant relationships to disclose
Peter F. Ehrlich
No relevant relationships to disclose
Geetika Khanna
No relevant relationships to disclose
Arlene Naranjo
No relevant relationships to disclose
Ying He
No relevant relationships to disclose
Thomas Edward Hamilton
No relevant relationships to disclose
Fernando Anthony Ferrer
No relevant relationships to disclose
Richard D. Glick
No relevant relationships to disclose
Kenneth William Gow
No relevant relationships to disclose
Douglas C. Barnhart
No relevant relationships to disclose
Jessica J. Kandel
No relevant relationships to disclose
Roshni Dasgupta
No relevant relationships to disclose
Fredric A. Hoffer
No relevant relationships to disclose
Sabah-E-Noor Servaes
No relevant relationships to disclose
Conrad Vincent Fernandez
No relevant relationships to disclose
Paul Edward Grundy
No relevant relationships to disclose
Jeffrey Dome
No relevant relationships to disclose